Matthew Biegler

Matthew Biegler

Analyst-Equity chez
Oppenheimer & Co., Inc. (Broker)
Consumer Services
Finance
Health Technology

Profil

Mr. Matthew Biegler is an Executive Director at Oppenheimer & Co., Inc. He is a Senior Analyst covering Emerging Biotechnology.
Prior to his Wall Street career, he spent over five years in the healthcare industry, most recently as a Consultant at Parexel International, a Contract Research Organization.
His areas of expertise include clinical trial design and strategy.
Mr. Biegler holds a Bachelor’s degree in Biochemistry and Molecular Biology from Boston University, and a Master’s in Biotechnology from the Columbia University Graduate School of Arts and Sciences.

Postes actifs de Matthew Biegler

SociétésPosteDébut
Analyst-Equity 01/05/2017

Anciens postes connus de Matthew Biegler

SociétésPosteFin
Analyst-Equity 01/05/2017
Corporate Officer/Principal 01/09/2014
Corporate Officer/Principal 01/12/2011
Voir l'expérience en détail de Matthew Biegler

Formation de Matthew Biegler

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

96

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Consumer Services

Finance

Consumer Services

Health Technology

Finance

Commercial Services

  1. Bourse
  2. Insiders
  3. Matthew Biegler
🔇